Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Ocean Biomedical, Inc. Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease | - | GlobeNewswire (USA) | ||
Di | Ocean Biomedical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
24.04. | Ocean Biomedical, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
24.04. | Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K | 453 | GlobeNewswire (Europe) | PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq")... ► Artikel lesen | |
16.04. | Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary | 3 | Reuters | ||
15.04. | Ocean Biomedical, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
15.04. | Ocean Biomedical, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
01.04. | Ocean Biomedical, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 5 | SEC Filings | ||
28.03. | Ocean Biomedical, Inc.: Ocean Biomedical Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL | 106 | GlobeNewswire (Europe) | Providence, RI, March 28, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists... ► Artikel lesen | |
25.03. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 3 | Reuters | ||
18.03. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 2 | Reuters | ||
08.03. | Ocean Biomedical, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
08.03. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 4 | Reuters | ||
29.02. | Ocean Biomedical, Inc.: Ocean Biomedical Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting | 27 | GlobeNewswire (USA) | ||
20.02. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 25 | Reuters | ||
12.02. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 4 | Reuters | ||
17.01. | Ocean Biomedical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
12.01. | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 1 | Reuters | ||
08.12.23 | Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview | 4 | Reuters | ||
05.12.23 | Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody | 287 | GlobeNewswire (Europe) | Results published in the Journal Immunity share discovery of a new mechanism by which Chi3L1 regulates breast cancer development and progression PROVIDENCE, Rhode Island, Dec. 05, 2023 (GLOBE NEWSWIRE)... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 361 |
EVOTEC | 338 |
TUI | 250 |
NVIDIA | 199 |
PLUG POWER | 192 |
BAYER | 181 |
NEL | 169 |
RHEINMETALL | 155 |
DEUTSCHE BANK | 142 |
BARRICK GOLD | 140 |
SIEMENS ENERGY | 139 |
BYD | 130 |
COMMERZBANK | 124 |
VOLKSWAGEN | 115 |
MERCEDES-BENZ | 111 |
TESLA | 109 |
ALIBABA | 105 |
RWE | 103 |
DEUTSCHE LUFTHANSA | 97 |
AMC ENTERTAINMENT | 91 |
AIXTRON SE | 90 |
ALLIANZ | 90 |
DEUTSCHE TELEKOM | 88 |
BASF | 83 |
SIEMENS | 81 |